Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845

The PHQ-9: Validity of a brief depression severity measure

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910

A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7

Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765

Diagnostic and Statistical Manual of Mental Disorders.

Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766

An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4

Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261

The global burden of headache: A documentation of headache prevalence and disability worldwide

Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444

Migraine prevalence, disease burden, and the need for preventive therapy

Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337

Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210

The Global Burden of Disease Study

Menken, M., Munsat, T. L., & Toole, J. F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.418 · Cited by 1,059

Experiencia con toxina botulínica en la migraña crónica

Sanz, A. C., Sánchez-Mateos, N. M., Hernández, C. S., Rodríguez, B. F., Santacruz, D. C., Rodríguez, A. M., Sanz, M. F. R., García, C. T., Becerra, P. G., Ros, M. F., et al. (2016) · Neurología · doi:10.1016/j.nrl.2016.09.004 · Cited by 16

OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience

Chiang, C., & Starling, A. J. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617731521 · Cited by 16

Fremanezumab for the preventive treatment of migraine

Silberstein, S. D., Cohen, J. M., & Yeung, P. P. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1627323 · Cited by 16

Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study

Katsarava, Z., Buse, D. C., Leroux, É., Lantéri‐Minet, M., Sakai, F., Matharu, M. S., Adams, A. M., Carr, K., Fanning, K. M., & Lipton, R. B. (2024) · Cephalalgia · doi:10.1177/03331024241274343 · Cited by 16

Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group Study

Seo, J., Smith, C. A., Thomas, C., Tervonen, T., Hareendran, A., Ford, J. H., Stauffer, V. L., Nicholson, R. A., Duffy, K. H., & Tockhorn‐Heidenreich, A. (2021) · Patient · doi:10.1007/s40271-021-00525-z · Cited by 15

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

McAllister, P., Winner, P. K., Ailani, J., Buse, D. C., Lipton, R. B., Chakhava, G., Josiassen, M. K., Lindstén, A., Mehta, L. R., Ettrup, A., et al. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01376-7 · Cited by 15

Epidemiology of migraine

Simmonds, L., Mehta, D., Cheema, S., & Matharu, M. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823356-6.00017-2 · Cited by 15

Therapie der chronischen Migräne mit Botulinumneurotoxin A

Ruscheweyh, R., Förderreuther, S., Gaul, C., Gendolla, A., Holle, D., Jürgens, T. P., Neeb, L., & Straube, A. M. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0534-0 · Cited by 15

Patient-Reported Outcome in Two Chronic Diseases: A Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma

Lucas, C., Aly, S., Touboul, C., Sellami, R., Guillaume, X., & Garcia, G. (2020) · Patient Related Outcome Measures · doi:10.2147/prom.s222597 · Cited by 15

Exploring Emotional Distress, Psychological Traits and Attitudes in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylaxis versus Withdrawal Treatment

Donisi, V., Mazzi, M. A., Gandolfi, M., Deledda, G., Marchioretto, F., Battista, S., Poli, S., Giansante, M., Geccherle, E., Perlini, C., et al. (2020) · Toxins · doi:10.3390/toxins12090577 · Cited by 17

Migraine predicts physical and pain symptoms among psychiatric outpatients

Hung, C., Liu, C., & Wang, S. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-19 · Cited by 15

Cognitive effects of onabotulinumtoxinA in chronic migraine

Ho, S., Darby, D., & Bear, N. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2019-000014 · Cited by 14

New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach

Simonetta, I., Riolo, R., Todaro, F., & Tuttolomondo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063018 · Cited by 16

Real-World Treatment Patterns and Outcomes Among Patients with Episodic Migraine in China: Results from the Adelphi Migraine Disease Specific Programme™

Zhao, H., Xiao, Z., Zhang, L., Ford, J. H., Zhong, S., Ye, W., Li, J., Tockhorn‐Heidenreich, A., Cotton, S. E., & Chen, C.-F. (2023) · Journal of Pain Research · doi:10.2147/jpr.s371887 · Cited by 16

Analysis of occipital nerve stimulation in studies of chronic migraine and broader implications of social media in clinical trials

Goadsby, P. J. (2012) · Cephalalgia · doi:10.1177/0333102412468680 · Cited by 14

Comparison of the clinical efficacy of bilateral and unilateral GON blockade at the C2 level in chronic migraine

Karaoğlan, M., Durmuş, İ. E., Küçükçay, B., Takmaz, S. A., & İnan, L. E. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05739-5 · Cited by 14

Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study

Sebastianelli, G., Casillo, F., Renzo, A. D., Abagnale, C., Cioffi, E., Parisi, V., Lorenzo, C. D., Serrao, M., Pierelli, F., Schoenen, J. E., et al. (2023) · Toxins · doi:10.3390/toxins15010076 · Cited by 14

Chronic Migraine: Burden, Comorbidities and Treatment

Özge, A., Uludüz, D., Yalın, O. Ö., Demirci, S., Karadaş, Ö., Uygunoğlu, U., & Sıva, A. (2018) · Turkish Journal Of Neurology · doi:10.4274/tnd.55563 · Cited by 14

Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

Argoff, C. E., Herzog, S., Smith, R. M., Kotak, S. V., Sopina, L., Saltarska, Y., Soni-Brahmbhatt, S., & Khan, F. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01764-9 · Cited by 13

Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management

Dougherty, C. O., & Silberstein, S. D. (2014) · Pain Practice · doi:10.1111/papr.12243 · Cited by 13

Impacto y situación de la Migraña en España: Atlas 2018

Garrido‐Cumbrera, M. (2019) · Editorial Universidad de Sevilla eBooks · doi:10.12795/9788447228324 · Cited by 14

Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data

Chandler, D., Szekely, C. A., Aggarwal, S., Cyprien, L., & Bensink, M. E. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00319-z · Cited by 13

Elevated Blood S100B Levels in Patients With Migraine: A Systematic Review and Meta-Analysis

Chu, C., Zhong, R., Cai, M., Li, N., & Lin, W. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.914051 · Cited by 13

Association of a Cyclical Migraine Phenotype With Disease Progression

Gallardo, V. J., Alpuente, A., & Pozo‐Rosich, P. (2022) · Neurology · doi:10.1212/wnl.0000000000200887 · Cited by 13

Update of Inpatient Treatment for Refractory Chronic Daily Headache

Lai, T., & Wang, S. (2015) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0531-y · Cited by 13

Outcome of Chronic Daily Headache or Chronic Migraine

Cho, S., Song, T., & Chu, M. K. (2015) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0534-8 · Cited by 13

Migraine day frequency in migraine prevention: longitudinal modelling approaches

Tanna, G. L. D., Porter, J. K., Lipton, R. B., Brennan, A., Palmer, S., Hatswell, A. J., Sapra, S. J., & Villa, G. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0664-5 · Cited by 13

Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine

Friedman, D. I., & Cohen, J. M. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20200018 · Cited by 13

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine

Ford, J. H., Kurth, T., Starling, A. J., Ayer, D. W., Wietecha, L. A., Port, M. D., Rettiganti, M. R., & Ruff, D. D. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14013 · Cited by 13

“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials

Asawavichienjinda, T., Sathitratanacheewin, S., & Chokesuwattanaskul, R. (2023) · Cephalalgia · doi:10.1177/03331024231161261 · Cited by 12

Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States

Dodick, D. W., Reed, M. L., Lee, L., Balkaran, B. L., Umashankar, K., Parikh, M., Gandhi, P., & Buse, D. C. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14684 · Cited by 13

Quality of life and work productivity and activity impairment among online survey respondents with migraine across a range of headache frequency

Ishii, R., Sakai, F., Sano, H., Nakai, M., Koga, N., & Matsukawa, M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1440733 · Cited by 12

Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population

An, Y.-C., Hung, K., Liang, C., Tsai, C., Tsai, C., Chen, S., Lin, Y., Lin, G., Yeh, P.-K., & Yang, F. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01850-y · Cited by 12

Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling

Mistry, H., Naghdi, S., Brown, A., Rees, S., Madan, J. J., Grove, A., Khanal, S., Duncan, C. N., Matharu, M. S., Cooklin, A., et al. (2024) · Health Technology Assessment · doi:10.3310/aywa5297 · Cited by 14

Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis

Peterlin, B. L., Bond, D. S., Ailani, J., Dodick, D. W., Liu, Y., Ferreira, R. D. A., Smith, J. H., Dabruzzo, B., Goadsby, P. J., & Trugman, J. M. (2024) · Cephalalgia · doi:10.1177/03331024241299753 · Cited by 12

Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims database

Ford, J. H., Schroeder, K. M., Buse, D. C., Joshi, S., Gelwicks, S., Foster, S. A., & Aurora, S. K. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1657716 · Cited by 12

Occipital nerve stimulation for primary headaches.

Young, W. B., & Silberstein, S. D. (2012) · PubMed · Cited by 12

Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis

Vikelis, M., Dermitzakis, E. V., Vlachos, G. S., Soldatos, P., Spingos, K. C., Litsardopoulos, P., Kararizou, E. G., & Argyriou, A. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010067 · Cited by 13

Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial

Schading‐Sassenhausen, S., Pohl, H., Gantenbein, A. R., Luechinger, R., Sándor, P. S., Riederer, F., Freund, P., & Michels, L. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01347-y · Cited by 12

Chronic migraine with and without medication overuse: experience in a hospital series of 434 patients

Rojo, E., Pedraza, M. I., Muñoz, I., Mulero, P., Ruíz, M., de la Cruz, C., Barón, J., Rodríguez, C., Herrero, S., & Guerrero, A. L. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.12.007 · Cited by 12

Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study

Okonkwo, R. I., Tockhorn‐Heidenreich, A., Stroud, C., Paget, M.-A., Matharu, M. S., & Tassorelli, C. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01322-7 · Cited by 11

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine

Buse, D. C., Nahas, S. J., Stewart, W. F., Armand, C., Reed, M. L., Fanning, K. M., Adams, A. M., & Lipton, R. B. (2023) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002801 · Cited by 11

Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review

Lipton, R. B., Gendolla, A., Abraham, L., Jenkins, A. K., Telfort, J., Blakeman, K. H., Saccone, P. A., Pustułka, I., Fotheringham, I., & Engh, A. M. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14854 · Cited by 11

Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trials

Goadsby, P. J., Jürgens, T. P., Brand‐Schieber, E., Nagy, K., Liu, Y., Boinpally, R., Stodtmann, S., & Trugman, J. M. (2025) · Cephalalgia · doi:10.1177/03331024251320610 · Cited by 11

Occipital Nerve Stimulation for Migraine: Update from Recent Multicenter Trials

Schwedt, T. J., Green, A. L., & Dodick, D. W. (2015) · Progress in neurological surgery · doi:10.1159/000434662 · Cited by 11

Neuroprotective Effect of Enriched Chicken Bone Broth as a Dietary Supplement in a Model of Migraine Mediated by Early Life Stress

Peterson, O. J., Cornelison, L. E., & Durham, P. L. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.0312 · Cited by 11

Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain

Vo, P. G., Swallow, E., Wu, E. Q., Zichlin, M. L., Katcher, N., Maier‐Peuschel, M., Naclerio, M., Ritrovato, D., Tiwari, S., Joshi, P., et al. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1953301 · Cited by 11

The prevalence and characteristics of visceral autonomic symptoms among migraineurs: A population-based study

Togha, M., Martami, F., Jafari, E., Ariyanfar, S., & Hashemi, S. M. (2021) · Cephalalgia · doi:10.1177/03331024211056849 · Cited by 11

Workplace productivity loss as a result of absenteeism and presenteeism in chronic and episodic migraine: a scoping review

Papakonstantinou, D., & Tomos, C. (2021) · International Journal of Workplace Health Management · doi:10.1108/ijwhm-05-2021-0123 · Cited by 11

Relation of hypertension with episodic primary headaches and chronic primary headaches in population of Rafsanjan cohort study

Mohammadi, M., Ayoobi, F., Khalili, P., Soltani, N. S., Vecchia, C. L., & Vakilian, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-03377-7 · Cited by 11

Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies

McAllister, P., Cohen, J. M., Campos, V. R., Ning, X., Janka, L., & Barash, S. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01438-4 · Cited by 11

Sex-related differences in migraine clinical features by frequency of occurrence: a cross-sectional study

Muñoz‐Gómez, E., Rodríguez, M. A., Serra‐Añó, P., Rubio, N. S., Mollà‐Casanova, S., & Inglés, M. (2023) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2022-0152 · Cited by 12

AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine

Silberstein, S. D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1339600 · Cited by 12

Stress Is Associated with Poor Outcome of Acute Treatment for Chronic Migraine: A Multicenter Study

Cha, M.-J., Kim, B., Moon, H., Ahn, J. Y., Oh, K., Kim, J. Y., Kim, B., Sohn, J., Chung, J.-M., Song, T., et al. (2017) · Pain Medicine · doi:10.1093/pm/pnx269 · Cited by 11

The features and burden of headaches within a chiropractic clinical population: A cross-sectional analysis

Moore, C., Leaver, A. M., Sibbritt, D. W., & Adams, J. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102276 · Cited by 11

Characteristics of migraine patients with Migraine Disability Assessment (MIDAS) scores in real-world clinical practice

Chia, V., Bogdanov, A., Yusuf, A., & Kallenbach, L. (2020) · Cephalalgia Reports · doi:10.1177/2515816320928463 · Cited by 11

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis

Diener, H., Dodick, D. W., Lipton, R. B., Adams, A. M., DeGryse, R. E., & Silberstein, S. D. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00198-w · Cited by 11

Occipital Nerve Stimulation for Chronic Migraine

Young, W. B. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0396-x · Cited by 11

The effectiveness of Orem's self-care program on headache-related disability in migraine patients.

Zarandi, F. M., Hamedanizadeh, F., Ebadi, A., & Raiesifar, A. (2016) · Europe PMC (PubMed Central) · Cited by 11

Experience with botulinum toxin in chronic migraine

Sanz, A. C., Sánchez-Mateos, N. M., Hernández, C. S., Rodríguez, B. F., Santacruz, D. C., Rodríguez, A. M., Sanz, M. F. R., García, C. T., Becerra, P. G., Ros, M. F., et al. (2018) · Neurología (English Edition) · doi:10.1016/j.nrleng.2016.09.001 · Cited by 11

The quality and reliability of short videos about migraine on Chinese social Media platforms (BiliBili and TikTok): A cross-sectional study

Qian, S., Gu, J., & Zhao, H. (2026) · Digital Health · doi:10.1177/20552076261415929 · Cited by 10

Competing treatments for migraine: a headache for decision-makers

Mistry, H., Naghdi, S., Underwood, M. R., Duncan, C. W., Madan, J. J., & Matharu, M. S. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01686-y · Cited by 10

Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biology

Fleischmann, R., Strauß, S., & Reuter, U. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2456464 · Cited by 13

Neuropsychological and Neuropsychiatric Features of Chronic Migraine Patients during the Interictal Phase

Lozano-Soto, E., Cruz-Gómez, Á. J., Rashid-López, R., Sanmartino, F., Espinosa‐Rosso, R., Forero, L., & González-Rosa, J. J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020523 · Cited by 12

Psychological Evaluation of a Primary Headache Patient

Turner, D. P., & Houle, T. T. (2012) · Pain Management · doi:10.2217/pmt.12.77 · Cited by 10

Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study

Li, H., Vincent, M. B., Zhang, X., Dennehy, E. B., Goodloe, R., Aurora, S. K., & Smith, T. R. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00167-3 · Cited by 10

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine

Silberstein, S. D., Diener, H., Dodick, D. W., Adams, A. M., DeGryse, R. E., & Lipton, R. B. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00199-9 · Cited by 11

Migraine Monitoring in the Time of COVID-19: Triggers and Protectors During a Pandemic

di Cola, F. S., Caratozzolo, S., Cesare, M. D., Liberini, P., Rao, R., & Padovani, A. (2021) · Pain Medicine · doi:10.1093/pm/pnab202 · Cited by 10

Southern Headache Society Supplement: The Neurobiology of Throbbing Pain in Migraine

Ahn, A. H. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02136.x · Cited by 10

Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting

Brüggenjürgen, B., Baker, T., Bhogal, R., & Ahmed, F. (2016) · SpringerPlus · doi:10.1186/s40064-016-2924-8 · Cited by 10

Migraine prophylactic management in neurology and primary care (2006–2015)

Jackson, J. L., Kay, C., Scholcoff, C., Nickoloff, S., & Fletcher, K. E. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9066-6 · Cited by 10

Chronic migraine and medication overuse

Diener, H., & Rizzoli, P. B. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823356-6.00008-1 · Cited by 9

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials

Silberstein, S. D., Diener, H., Dodick, D. W., Sommer, K., & Lipton, R. B. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14743 · Cited by 11

Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model

Cornelison, L. E., Hawkins, J. L., Woodman, S. E., & Durham, P. L. (2020) · PAIN Reports · doi:10.1097/pr9.0000000000000881 · Cited by 9

Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine

Argyriou, A. A., Dermitzakis, E. V., Rikos, D., Xiromerisiou, G., Soldatos, P., Litsardopoulos, P., & Vikelis, M. (2024) · Toxins · doi:10.3390/toxins16020106 · Cited by 10

Manual therapy for chronic migraine: a pragmatic randomised controlled trial study protocol

Odell, J., Clark, C., Hunnisett, A., Ahmed, O. H., & Branney, J. (2019) · Chiropractic & Manual Therapies · doi:10.1186/s12998-019-0232-4 · Cited by 10

Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)

Tepper, S. J., Ailani, J., Ford, J. H., Nichols, R., Li, L. Q., Kemmer, P., Hand, A. L., & Tockhorn‐Heidenreich, A. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-021-01115-5 · Cited by 9

Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials

Tanna, G. L. D., Porter, J. K., Lipton, R. B., Hatswell, A. J., Sapra, S. J., & Villa, G. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1242-6 · Cited by 9

Impact of episodic and chronic vestibular disorders on health-related quality of life and functioning—results from the DizzyReg patient registry

Strobl, R., Harajli, S., Huppert, D., Zwergal, A., & Grill, E. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03345-w · Cited by 8

Patients’ Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb)

Seng, E. K., Lampl, C., Viktrup, L., Lenderking, W. R., Karn, H., Hoyt, M. L., Kim, G., Ruff, D. D., Ossipov, M. H., & Vincent, M. B. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00652-z · Cited by 9

Feasibility, acceptability, and fidelity of remote‐delivered abbreviated mindfulness‐based cognitive therapy interventions for patients with migraine and depressive symptoms

Seng, E. K., Hill, J. D., Reeder, A. K., Visvanathan, P. D., Wells, R. E., Lipton, R. B., Minen, M. T., & Shallcross, A. J. (2024) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14857 · Cited by 8

A narrative review of autophagy in migraine

Huang, Y., Li, H., Yu, Q., & Pan, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1500189 · Cited by 8

Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE)

Matsumori, Y., Yamada, H., Nagaseki, Y., Shimizu, K., Nagy, K., Matsuzawa, R., Otani, T., He, M. Y., Guo, H., Ahmadyar, G., et al. (2025) · Cephalalgia · doi:10.1177/03331024251374569 · Cited by 8

Quality of life in patients with chronic migraine: relation to migraine severity, depression and sleep disturbances

Tatarinova, K., & Artemenko, A. R. (2017) · Neuromuscular Diseases · doi:10.17650/2222-8721-2017-7-1-43-53 · Cited by 8

Treatment and management of migraine in neurological ambulatory practice in Poland by indicating therapy with monoclonal anti-CGRP antibodies

Domitrz, I., Lipa, A., Rózniecki, J., Stępień, A., & Kozubski, W. P. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0054 · Cited by 8

Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card survey

Buse, D. C., Cady, R. K., Starling, A. J., Buzby, M., Spinale, C., Steinberg, K., Lenaburg, K., & Kymes, S. M. (2024) · BMC Neurology · doi:10.1186/s12883-024-03732-x · Cited by 8

Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk

Alwhaibi, M., Deb, A., & Sambamoorthi, U. (2016) · Pain Research and Treatment · doi:10.1155/2016/8538101 · Cited by 8

The treatment efficacy of galcanezumab for migraine: A meta-analysis of randomized controlled trials

Ren, Z., Zhang, H., Wang, R., Yuan, Q., Pan, L., & Chen, C. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105428 · Cited by 8

Using Cognitive Behavioral Therapy Techniques to Treat Migraine

Seng, E. K. (2018) · Journal of Health Service Psychology · doi:10.1007/bf03544665 · Cited by 8

Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study

Alpuente, A., Gallardo, V. J., Torres‐Ferrús, M., Lasaosa, S. S., Guerrero, A. L., Laínez, J. M., Viguera, J., Gago‐Veiga, A. B., Irimia, P., del Río, M. S., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14331 · Cited by 8

Outcomes of Occipital Nerve Stimulation for Craniofacial Pain Syndromes

Magown, P., Becker, W. J., & Kiss, Z. H. T. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.259 · Cited by 8

Assessment of Utility in Migraine: Mapping the Migraine-Specific Questionnaire to the EQ-5D-5L

Ahadi, M. S., Vahidpour, N., Togha, M., Daroudi, R., Nadjafi-Semnani, F., Mohammadshirazi, Z., Akbarisari, A., & Ghorbani, Z. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2020.12.003 · Cited by 8

Management of headaches in children and adolescents

O'Donnell, D. M., & Agin, A. (2021) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2021.101034 · Cited by 8

Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migraine

Dermitzakis, E. V., Kouroudi, A., Argyriou, A. A., Spingos, K. C., Bilias, K., & Vikelis, M. (2022) · BMC Neurology · doi:10.1186/s12883-022-02968-9 · Cited by 8

Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction

Dermitzakis, E. V., Kouroudi, A., Argyriou, A. A., Spingos, K. C., Bilias, K., & Vikelis, M. (2022) · Medicina · doi:10.3390/medicina59010031 · Cited by 8

Is daily headache related to asthma? Results from a population-based survey

Lee, Y. S., Lee, G. D., Lee, J. S., Rhee, C. K., Shim, T. S., Kim, W. S., Lee, S., & Oh, Y. (2013) · Journal of Asthma · doi:10.3109/02770903.2013.795587 · Cited by 8

How general practitioners treat migraine patients—evaluation of a headache guideline

Zielman, R., Veenstra, P. J. L., van Zwet, E., & Berg, J. (2012) · Cephalalgia · doi:10.1177/0333102412454944 · Cited by 8

More is not Always Better: An Epidemiological Assessment of Migraine Frequency and the Impact on Relationships

Wachholtz, A., Bhowmick, A., Herbert, L., & Marcus, D. A. (2017) · Journal of Pain Management & Medicine · doi:10.35248/2684-1320.17.3.126 · Cited by 8

Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA

Martínez‐Pías, E., Peral, Á. L. G., Sierra, Á., Trigo-López, J., & García‐Azorín, D. (2021) · Toxins · doi:10.3390/toxins13060432 · Cited by 8

Association of Migraine Comorbidities with Quality of Life, Work Productivity and Daily Activities: Survey and Medical Claims Data in Japan

Takeshima, T., Nakayama, T., Sano, H., Koga, N., & Matsukawa, M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03236-1 · Cited by 7

Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan

Wang, S., Wang, P.-J., Fuh, J., Peng, K., & Ng, K. (2012) · Cephalalgia · doi:10.1177/0333102412468668 · Cited by 86

POH02 Impact of chronic vs episodic migraine on disability, health-related quality of life and healthcare resource utilisation in the UK

Goadsby, P. J., Lipton, R. B., Varon, S. F., Buse, D. C., Kawata, A., Wilcox, T. K., Blumenfield, A., & Girod, I. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.226340.136

Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine

Silberstein, S. D., Lee, L., Gandhi, K., Fitzgerald, T. P., Bell, J., & Cohen, J. M. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13421 · Cited by 99

Burden of Episodic and Chronic Migraine in Patients Who Had Failed Multiple Preventive Treatments From France, Spain, and the United Kingdom

Díaz-Insa, S., Lasaosa, S. S., Driessen, M. T., Cohen, J. M., Lee, L., & Goadsby, P. J. (2024) · Acta Neurologica Scandinavica · doi:10.1155/ane/4714514 · Cited by 2

The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries

Doane, M. J., Gupta, S., Fang, J., Laflamme, A. K., & Vo, P. G. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00196-2 · Cited by 50